Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting Serine in Cancer: Is Two Better Than One?

Trends in cancer(2021)10.1016/j.trecan.2021.06.004Source: DataRank Database

Targeting Serine in Cancer: Is Two Better Than One? is a research paper published in Trends in cancer (2021). On theSindex it has a DataRank of 0. It has been cited 31 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access31 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.11)OA: greenTopics (62)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Lorenzo Galluzzi ORCID,David C. Montrose ORCID,Aitziber Buqué

Live enrichment

PubMed:34219053 PMC:PMC9097339 OpenAlex:https://openalex.org/W3173334030

National Cancer Institute

Grant: K22CA226033

National Institutes of Health

Grant: 1K22CA226033-01

Reducing serine biosynthesis and utilization as a novel approach for colon cancer prevention

AstraZeneca

Boehringer Ingelheim

Leukemia and Lymphoma Society

National Institutes of Health

Stand Up To Cancer

FWCI

1.11

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9097339

publisherhttps://api.elsevier.com/content/article/PII:S2405803321001345?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803321001345?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.trecan.2021.06.004

Fields of Study

Epigenetics and DNA MethylationHistone Deacetylase Inhibitors ResearchAmino Acid Enzymes and Metabolism0301 basic medicine0303 health sciences03 medical and health sciencesAntimetabolites, AntineoplasticCell Line, TumorCombined Modality TherapyDiet, Protein-RestrictedDietary ProteinsHumansNeoplasmsPhosphoglycerate DehydrogenasePhosphoric Monoester HydrolasesSerineTransaminasesXenograft Model Antitumor Assays

MeSH Terms

TransaminasesAntimetabolites, AntineoplasticCombined Modality TherapyDietary ProteinsHumansNeoplasmsPhosphoric Monoester HydrolasesSerineDiet, Protein-RestrictedXenograft Model Antitumor AssaysCell Line, TumorPhosphoglycerate Dehydrogenase

Keywords

SerineLimitingEndogenyCancerCancer researchMedicineBlocking (statistics)Cancer cellComputational biologyBioinformaticsBiologyComputer scienceCell biologyPhosphorylationInternal medicineDNA damageGlycineColorectal CancerPhgdhPsat1PsphAntimetabolites, AntineoplasticCombined Modality TherapyXenograft Model Antitumor AssaysPhosphoric Monoester HydrolasesCell Line, TumorNeoplasmsDiet, Protein-RestrictedHumansDietary ProteinsPhosphoglycerate DehydrogenaseTransaminases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being